These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2733361)

  • 1. [Specific immunity in patients with severe burns complicated by Pseudomonas infection].
    Fedorovskaia EA; Nazarchuk LV
    Klin Khir (1962); 1989; (3):35-7. PubMed ID: 2733361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of infection on the immune system in burns in animal experiments].
    Böhland W; Sauer D
    Z Exp Chir; 1978; 11(1):32-6. PubMed ID: 417479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermal injury-induced non-specific resistance to fatal Pseudomonas aeruginosa burn-infection in mice.
    Pinto M; Zehavi-Willner T
    Jpn J Exp Med; 1989 Oct; 59(5):189-96. PubMed ID: 2559218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of using polyvalent Pseudomonas aeruginosa vaccine in children with burns by various medical centers].
    Bbukowska D; Serafińska D; Rudowski W; Hoffman S; Olański W; Gardzińska E; Popiel D; Jedrzejczak G; Czarnecka I
    Pol Tyg Lek; 1989 Oct 23-Nov 6; 44(43-45):924-7. PubMed ID: 2518666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role and importance of immunotherapy in treating the infectious complications of burn patients].
    Panchenkov NR; Murazian RI
    Probl Gematol Pereliv Krovi; 1982 Feb; 27(2):46-8. PubMed ID: 7063469
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sensitization to Pseudomonas aeruginosa in thermal burn patients].
    Kolker II; Minkina AE; Fradkin VA; Panova IuM; Morozov SS
    Klin Med (Mosk); 1982 Jun; 60(6):103-7. PubMed ID: 6811796
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyocyanic sepsis in burn disease].
    Baliabin AA; Krasnopevtseva OS; Pinchuk VM
    Arkh Patol; 1972; 34(11):31-7. PubMed ID: 4630397
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical use of a Soviet polyvalent corpuscular pyocyanic vaccine for the prevention of Pseudomonas aeruginosa infection in thermal burn victims].
    Gerasimova LI; Moroz AF; Radkevich SA; Sveshnikov AI; Mizikin EV
    Khirurgiia (Mosk); 1980 Nov; (11):36-41. PubMed ID: 6777578
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of infection of thermal injury by Pseudomonas aeruginosa PAO1 on the murine cytokine response.
    Rumbaugh KP; Colmer JA; Griswold JA; Hamood AN
    Cytokine; 2001 Nov; 16(4):160-8. PubMed ID: 11792126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of plasma humoral recognition factor activity following burn injury.
    Goldman AS; Rudloff HB; McNamee R; Loose LD; DiLuzio NR
    J Reticuloendothel Soc; 1974 Mar; 15(3):193-8. PubMed ID: 4838130
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-Pseudomonas immunoglobulin. III. Preliminary clinical evaluation.
    Sakiel S; Schiller B; Buchowicz I; Kotkowska-Tomanek E
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):517-21. PubMed ID: 6422901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune blood substitutes in acute burn toxemia in children].
    Mel'nik DD; Perveev VI; Moskvin VI
    Vestn Khir Im I I Grek; 1984 Dec; 133(12):80-4. PubMed ID: 6528454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection of severe burns. New perspectives of treatment in primary care].
    Porras Pastor JM; Porras Pastor FJ; Román Manzano A; Sánchez Jorge M; Jiménez García JF; Granados Alba A; Lafuente Robles N
    Rev Enferm; 2007 Jan; 30(1):27-8. PubMed ID: 17380632
    [No Abstract]   [Full Text] [Related]  

  • 14. [Immune status in diabetic patients with pyo-necrotic lesions of lower extremities].
    Zemlianoĭ AB; Pal'tsyn AA; Svetukhin AM; Kolokol'chikova EG; Chervonskaia NV; Badikova AK; Bobrovnikov AE; Puchkova LS; Grishina IA
    Khirurgiia (Mosk); 2002; (1):34-5. PubMed ID: 11875946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of interleukin-6 in the development of sepsis. Part I: Study in a standardized contact burn murine model.
    Pallua N; von Heimburg D
    Crit Care Med; 2003 May; 31(5):1490-4. PubMed ID: 12771623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection in burn patients: the problems of pathogenesis, prevention and treatment].
    Alekseev AA; Iakovlev VP; Fedorov VD
    Khirurgiia (Mosk); 1999; (6):4-9. PubMed ID: 10410507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and resistance of Pseudomonas aeruginosa in severely burned patients: a 10-year retrospective study.
    Lipový B; Rihová H; Hanslianová M; Gregorová N; Suchánek I; Brychta P
    Acta Chir Plast; 2010; 52(2-4):39-43. PubMed ID: 21749009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of natural killer dendritic cells in host resistance against Pseudomonas aeruginosa infection after thermal injury in mice.
    Kawasaki T; Kobayashi M; Herndon DN; Suzuki F
    Shock; 2010 Jul; 34(1):83-9. PubMed ID: 20016409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pathogenetic and immunotherapeutic significance of a cutaneous burn toxin in experimental pseudomonas infection].
    Postel J; Allgöwer M; Burkhart F; Müller W; Städtler K; Schoenenberger GA
    Helv Chir Acta; 1974 Mar; 41(1-2):7-11. PubMed ID: 4436111
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum IgG concentrations and antibody titer of burn patients after preventive intravenous IgG substitution with a Pseudomonas immunoglobulin].
    Stuttmann R; Hartert M; Jahn M; Spilker G; Doehn M
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():48-55. PubMed ID: 8499751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.